Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANTHEM: Prophylactic Antibiotic Treatment in ESKD Patients on Hemodialysis
NCT05248620Recruiting
- Sponsor
- Zealand University Hospital
- Start
- Feb 2022
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of amoxicillin and clavulanic acid in bloodstream infection (BSI) and Infection (2 arms), sponsored by Zealand University Hospital. Primary endpoints: Blood stream infection at 6 months and Severe blood culture negative infection at 6 months. Started Feb 2022; status: recruiting.
02
Drugs
amoxicillinclavulanic acid
03
Conditions
bloodstream infection (BSI)Infection
Beyond the preview
Go deeper on NCT05248620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248620.